Ignite Creation Date:
2024-05-06 @ 9:52 AM
Last Modification Date:
2024-10-26 @ 12:20 PM
Study NCT ID:
NCT03093116
Status:
RECRUITING
Last Update Posted:
2024-02-07
First Post:
2017-03-06
Brief Title:
A Study of Repotrectinib TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK ROS1 or NTRK1-3 Rearrangements
Sponsor:
Organization:
Turning Point Therapeutics Inc